Safety issues of methylglyoxal and potential scavengers

The health safety of methylglyoxal (MGO) has been recognized as a key issue owing to its ultra-high reactivity toward some key biomolecules such as amino acids, proteins, DNA, sulfhydryl- and basic nitrogen-containing compounds, including amino-bearing neurotransmitters. In this review, we have summ...

Full description

Bibliographic Details
Main Author: Shiming LI, Siyu LIU, Chi-Tang HO
Format: Article
Language:English
Published: Higher Education Press 2018-07-01
Series:Frontiers of Agricultural Science and Engineering
Subjects:
Online Access:http://academic.hep.com.cn/fase/fileup/2095-7505/PDF/1510126240023-940963069.pdf
_version_ 1819264673250279424
author Shiming LI, Siyu LIU, Chi-Tang HO
author_facet Shiming LI, Siyu LIU, Chi-Tang HO
author_sort Shiming LI, Siyu LIU, Chi-Tang HO
collection DOAJ
description The health safety of methylglyoxal (MGO) has been recognized as a key issue owing to its ultra-high reactivity toward some key biomolecules such as amino acids, proteins, DNA, sulfhydryl- and basic nitrogen-containing compounds, including amino-bearing neurotransmitters. In this review, we have summarized the endo- and exogenous sources of MGO and its accumulation inside the body due to high intake, abnormal glucose metabolism and or malfunctioning glyoxalases, and review the debate concerning the adverse functionality of MGO ingested from foods. Higher than normal concentrations of MGO in the circulatory system and tissues have been found to be closely associated with the production of advanced glycation end products (AGEs), increased oxidative stress, elevated inflammation and RAGE (AGE receptors) activity, which subsequently progresses to a pathological stage of human health, such as diabetes complications, cancer, cardiovascular and degenerative diseases. Having illustrated the mechanisms of MGO trapping in vivo, we advocate the development of efficient and efficacious MGO scavengers, either assisting or enhancing the activity of endogenous glyoxalases to facilitate MGO removal, or providing phytochemicals and functional foods containing them, or pharmaceuticals to irreversibly bind MGO and thus form MGO-complexes that are cleared from the body.
first_indexed 2024-12-23T20:33:13Z
format Article
id doaj.art-66d94244973442e8892d983750de30c3
institution Directory Open Access Journal
issn 2095-7505
language English
last_indexed 2024-12-23T20:33:13Z
publishDate 2018-07-01
publisher Higher Education Press
record_format Article
series Frontiers of Agricultural Science and Engineering
spelling doaj.art-66d94244973442e8892d983750de30c32022-12-21T17:32:10ZengHigher Education PressFrontiers of Agricultural Science and Engineering2095-75052018-07-015331232010.15302/J-FASE-2017174Safety issues of methylglyoxal and potential scavengersShiming LI, Siyu LIU, Chi-Tang HO01. Hubei Key Laboratory for Processing and Application of Catalytic Materials, College of Chemistry and Chemical Engineering, Huanggang Normal University, Huanggang 438000, China; 2. Department of Food Science, Rutgers University, New Brunswick, NJ 08901, USAThe health safety of methylglyoxal (MGO) has been recognized as a key issue owing to its ultra-high reactivity toward some key biomolecules such as amino acids, proteins, DNA, sulfhydryl- and basic nitrogen-containing compounds, including amino-bearing neurotransmitters. In this review, we have summarized the endo- and exogenous sources of MGO and its accumulation inside the body due to high intake, abnormal glucose metabolism and or malfunctioning glyoxalases, and review the debate concerning the adverse functionality of MGO ingested from foods. Higher than normal concentrations of MGO in the circulatory system and tissues have been found to be closely associated with the production of advanced glycation end products (AGEs), increased oxidative stress, elevated inflammation and RAGE (AGE receptors) activity, which subsequently progresses to a pathological stage of human health, such as diabetes complications, cancer, cardiovascular and degenerative diseases. Having illustrated the mechanisms of MGO trapping in vivo, we advocate the development of efficient and efficacious MGO scavengers, either assisting or enhancing the activity of endogenous glyoxalases to facilitate MGO removal, or providing phytochemicals and functional foods containing them, or pharmaceuticals to irreversibly bind MGO and thus form MGO-complexes that are cleared from the body.http://academic.hep.com.cn/fase/fileup/2095-7505/PDF/1510126240023-940963069.pdfreactive carbonyl species|advanced glycation end products|diabetes, brain health|methylglyoxal trapping agents
spellingShingle Shiming LI, Siyu LIU, Chi-Tang HO
Safety issues of methylglyoxal and potential scavengers
Frontiers of Agricultural Science and Engineering
reactive carbonyl species|advanced glycation end products|diabetes, brain health|methylglyoxal trapping agents
title Safety issues of methylglyoxal and potential scavengers
title_full Safety issues of methylglyoxal and potential scavengers
title_fullStr Safety issues of methylglyoxal and potential scavengers
title_full_unstemmed Safety issues of methylglyoxal and potential scavengers
title_short Safety issues of methylglyoxal and potential scavengers
title_sort safety issues of methylglyoxal and potential scavengers
topic reactive carbonyl species|advanced glycation end products|diabetes, brain health|methylglyoxal trapping agents
url http://academic.hep.com.cn/fase/fileup/2095-7505/PDF/1510126240023-940963069.pdf
work_keys_str_mv AT shiminglisiyuliuchitangho safetyissuesofmethylglyoxalandpotentialscavengers